A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

ABSTRACT: The main purpose of this 3-part study is to evaluate the safety and efficacy of the study drug known as LY2880070 in participants with advanced or metastatic solid tumors.

DISEASE(S): Endometrial Cancer,Sarcoma,Triple Negative Breast Neoplasms,Colorectal Cancer,Soft Tissue Sarcoma,Triple Negative Breast Cancer,Advanced Cancer,Pancreatic Cancer,Rectal Cancer,Endometrial Neoplasms,Breast Neoplasms,Breast Cancer,Neoplasms,Ovarian Cancer,Rectal Neoplasms,Pancreas Cancer,Neoplasm Metastasis,Colon Cancer,Colorectal Neoplasms,Ovarian Neoplasms,Pancreatic Neoplasms,Solid Tumors

PROVIDER: 2204438 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR